[
  {
    "start": "0",
    "end": "185000"
  },
  {
    "text": "So, when I first came to town,  the Red Sox hadn't won for 42 years.    Now it's been 86 years, so the whole town all of a sudden changes  ",
    "start": "0",
    "end": "8000"
  },
  {
    "text": "its psychology.  A time for great celebration,    at least for you Red Sox fans.  At the, after last lecture I had an  ",
    "start": "8000",
    "end": "17000"
  },
  {
    "text": "interesting conversation with one of you.  One of you came up to me and   said very politely,  Professor Weinberg, do you have some  ",
    "start": "17000",
    "end": "26000"
  },
  {
    "text": "lecture notes that you have written out what the important points of the   lecture are that you could give me or that you could give us?   ",
    "start": "26000",
    "end": "35000"
  },
  {
    "text": "And I said, you know,  I, I'm not really interested in   doing that.  And the reason I'm not really interested in doing that is  ",
    "start": "35000",
    "end": "43000"
  },
  {
    "text": "that the main function of this course is to enable you to listen to,    when somebody is talking about conceptually complex things and to  ",
    "start": "43000",
    "end": "51000"
  },
  {
    "text": "distil what's being said and to figure out in your own mind what's   important and what is just another piece of drivel coming out of my  ",
    "start": "51000",
    "end": "59000"
  },
  {
    "text": "mouth or Eric Lander's mouth.  In fact, speaking for him,    if I will allow, can allow myself,  and myself, in the end we don't  ",
    "start": "59000",
    "end": "68000"
  },
  {
    "text": "really care that much whether you know the difference between DNA and   RNA or proteins and phospholipids.  What we're really interested in  ",
    "start": "68000",
    "end": "76000"
  },
  {
    "text": "doing is to use this course as a vehicle for pushing you to get your   brains functioning even better than they already are.   ",
    "start": "76000",
    "end": "84000"
  },
  {
    "text": "And, therefore, if you learn in this course how to,    to think about very complex subjects and figure out what's really going  ",
    "start": "84000",
    "end": "92000"
  },
  {
    "text": "on then this course will have more than paid for itself in terms of the   energy you put into it.  So, that's part of the reason why we  ",
    "start": "92000",
    "end": "101000"
  },
  {
    "text": "don't provide you with lecture outlines.  We want you to figure out   what's important on your own.  Being able to do so will itself be  ",
    "start": "101000",
    "end": "111000"
  },
  {
    "text": "a major triumph.  At the end of our discussion last   time we talked about the cell cycle,  the fact that it has, has four major  ",
    "start": "111000",
    "end": "120000"
  },
  {
    "text": "active phases.  G1, S, G2 and mitosis.    We talked about mitosis.  And we talked about the fact that  ",
    "start": "120000",
    "end": "129000"
  },
  {
    "text": "when cells emerge from mitosis,  from M phase in the absence of   growth stimulatory factors then they go into G zero.   ",
    "start": "129000",
    "end": "138000"
  },
  {
    "text": "And if they're provided with growth stimulatory factors then they'll go   back into the active cell cycle.  And this G zero phase we talked  ",
    "start": "138000",
    "end": "147000"
  },
  {
    "text": "about is a quiescence phase,  it's a resting phase.    In fact, there are two kinds of quiescent cells in our bodies.   ",
    "start": "147000",
    "end": "156000"
  },
  {
    "text": "Those that go into quiescence,  non-growth reversibly, and are able   to reemerge back into the active cell cycle, and those cells which  ",
    "start": "156000",
    "end": "164000"
  },
  {
    "text": "have irreversibly retreated from the active cell cycle.    So, for example, there are many cells in our brain where no matter  ",
    "start": "164000",
    "end": "172000"
  },
  {
    "text": "what you do to them they will never be able to go back into the active   cell cycle.  And they are,  in that sense, considered to be  ",
    "start": "172000",
    "end": "180000"
  },
  {
    "text": "post-mitotic.  Post-mitotic meaning that they will   never again grow.  It's really not clear which of the  ",
    "start": "180000",
    "end": "189000"
  },
  {
    "start": "185000",
    "end": "288000"
  },
  {
    "text": "post-mitotic cells,  which tissues in the body harbor,    harbor post-mitotic cells.  We used to think that most of the  ",
    "start": "189000",
    "end": "198000"
  },
  {
    "text": "differentiated cells in our body are post-mitotic.  And when I say   differentiated,  a topic we will not get into for the  ",
    "start": "198000",
    "end": "208000"
  },
  {
    "text": "moment, what I mean is that different cells in different parts   of the body have become differentiated by becoming very  ",
    "start": "208000",
    "end": "217000"
  },
  {
    "text": "specialized to become neurons or becoming liver cells or to becoming   skin cells and so forth.  And it is probably the case that  ",
    "start": "217000",
    "end": "226000"
  },
  {
    "text": "there are many kinds of differentiated cells in the body   which once they differentiate will no longer enter into the active cell  ",
    "start": "226000",
    "end": "234000"
  },
  {
    "text": "cycle.  Now, getting back to this.    As I also mentioned,  if we look at a Petri dish then and  ",
    "start": "234000",
    "end": "242000"
  },
  {
    "text": "we put cells like fibroblast,  connective tissue cells in the   bottom of the Petri dish,  as I told you last time, if you  ",
    "start": "242000",
    "end": "250000"
  },
  {
    "text": "provide those cells with medium which contains all the requisite   nutrients, these cells will sit here happily for an extended period of  ",
    "start": "250000",
    "end": "258000"
  },
  {
    "text": "time but will not proliferate.  However, if you add to their serum,    add their medium, you add serum to this medium.  Serum usually comes  ",
    "start": "258000",
    "end": "266000"
  },
  {
    "text": "from cows, so therefore it's called bovine serum.    Then the serum,  in addition to the nutrients present  ",
    "start": "266000",
    "end": "274000"
  },
  {
    "text": "in the, in the medium will indeed provoke these cells to proliferate,    and there are agents in the serum,  in fact there are agents which are  ",
    "start": "274000",
    "end": "283000"
  },
  {
    "text": "called growth factors which are contained within the serum which are   responsible for inducing these,  these cells to begin to proliferate.   ",
    "start": "283000",
    "end": "293000"
  },
  {
    "start": "288000",
    "end": "510000"
  },
  {
    "text": "Well, it's instructive just for a moment to step back and ask   ourselves what actually is serum?  How do you get serum?   ",
    "start": "293000",
    "end": "301000"
  },
  {
    "text": "And the way you get serum is you take blood and you allow it to clot.    And when blood clots the platelets in the, in the blood,   ",
    "start": "301000",
    "end": "309000"
  },
  {
    "text": "platelets are small cellular fragments, they have an intact   plasma membrane but they're just,  they're very tiny, they don't have a  ",
    "start": "309000",
    "end": "316000"
  },
  {
    "text": "nucleus, and these A,  A nuclear fragments, these platelets,    when blood is induced to clot the platelets aggregate with one another  ",
    "start": "316000",
    "end": "324000"
  },
  {
    "text": "and you form a big clump,  and that, a clot settles to the   bottom of the test-tube.  But in the context of wounding,   ",
    "start": "324000",
    "end": "332000"
  },
  {
    "text": "let's say you make a cut on your skin, what happens is that blood   rushes into the site of,  of the, the cut or the wound,   ",
    "start": "332000",
    "end": "340000"
  },
  {
    "text": "clotting occurs in order to create coagulation.  And why is there   coagulation?  In order to staunch the bleeding.  In order to prevent  ",
    "start": "340000",
    "end": "348000"
  },
  {
    "text": "there to be further hemorrhage,  further loss of blood.  But at the   same time, as the platelets are aggregating to help form the  ",
    "start": "348000",
    "end": "356000"
  },
  {
    "text": "structure of the clot that,  that creates a physical barrier to   prevent further bleeding,  simultaneously the platelets are  ",
    "start": "356000",
    "end": "364000"
  },
  {
    "text": "releasing a lot of growth factors into the medium around them.    Why are they doing that?  Because what's happening  ",
    "start": "364000",
    "end": "373000"
  },
  {
    "text": "simultaneous with stopping the bleeding is that the platelets are,    are releasing growth factors which are used in order to begin to  ",
    "start": "373000",
    "end": "383000"
  },
  {
    "text": "reconstruct and heal the site of wounding.  Consequently,    what happens is that the platelets release growth factors.   ",
    "start": "383000",
    "end": "393000"
  },
  {
    "text": "These growth factors stimulate cells right around the sides of the wound   which are still viable and have not been destroyed to begin to  ",
    "start": "393000",
    "end": "402000"
  },
  {
    "text": "proliferate in order to reconstruct and intact tissue.    One of the most important of these,  of these, of these factors that they  ",
    "start": "402000",
    "end": "411000"
  },
  {
    "text": "release is platelet-derived growth factor.  Remember GF is   just growth factor.  And platelet-derived growth factor,   ",
    "start": "411000",
    "end": "420000"
  },
  {
    "text": "or as it's called in the trade PDGF,  I mentioned it briefly last time, is   a very potent mitogen.  A mitogen is a growth stimulatory  ",
    "start": "420000",
    "end": "429000"
  },
  {
    "text": "agent.  It's an important mitogen for fibroblasts.    Fibroblasts, as you recall,  are the connective tissue, the  ",
    "start": "429000",
    "end": "438000"
  },
  {
    "text": "connective tissue cells that are found throughout the body.    And, therefore, if you were to,  for example, add platelet-derived  ",
    "start": "438000",
    "end": "448000"
  },
  {
    "text": "growth factor,  PDGF to those fibroblasts that were   sitting there in G zero,  PDGF will stimulate the fibroblasts  ",
    "start": "448000",
    "end": "457000"
  },
  {
    "text": "to begin to enter into the active cell cycle, to exit from G zero,    to enter into G1, and therefore to complete a, a full cell cycle.   ",
    "start": "457000",
    "end": "467000"
  },
  {
    "text": "And, by the way,  recall what I said before,    that after the cells leave the active, leave G zero and move  ",
    "start": "467000",
    "end": "475000"
  },
  {
    "text": "throughout the active cell cycle and they have a lot of growth factors,    they'll go all the way around the active growth cycle to mitosis.   ",
    "start": "475000",
    "end": "483000"
  },
  {
    "text": "And when they emerge from mitosis,  once again they'll ask themselves   the question whether it's a good idea to continue to be in the active  ",
    "start": "483000",
    "end": "492000"
  },
  {
    "text": "cell cycle or whether they should exit into G zero,    perhaps doing so reversibly.  Interestingly, if you look at the  ",
    "start": "492000",
    "end": "501000"
  },
  {
    "text": "way that the cell cycle is organized then what you see is the following,    if I can draw the cell cycle again.  Here's G1.   ",
    "start": "501000",
    "end": "510000"
  },
  {
    "start": "510000",
    "end": "620000"
  },
  {
    "text": "Here's S phase.  And here's G2.  And right at,    at a distinct point toward the end of G1 is something called the  ",
    "start": "510000",
    "end": "518000"
  },
  {
    "text": "restriction point,  which is going to be very   interesting shortly.  And what happens is after cells  ",
    "start": "518000",
    "end": "526000"
  },
  {
    "text": "emerge from G,  from mitosis and they move   throughout the,  the most of G1 they're continually  ",
    "start": "526000",
    "end": "534000"
  },
  {
    "text": "assessing their extracellular environment to determine whether or   not there are enough growth factors around to justify their continuing  ",
    "start": "534000",
    "end": "542000"
  },
  {
    "text": "the rest of the cell cycle.  And ultimately they'll reach this   restriction point,  or as it's sometimes called the R  ",
    "start": "542000",
    "end": "551000"
  },
  {
    "text": "point, and here they will make the final go versus no-go decision.    So, if there have historically been enough growth factors from the  ",
    "start": "551000",
    "end": "559000"
  },
  {
    "text": "beginning of G1 all the way to the R point then cells will commit   themselves essentially irreversibly to going through the entire rest of  ",
    "start": "559000",
    "end": "567000"
  },
  {
    "text": "the cell cycle, through M.  Conversely, if cells reach up to   this R point and they calculate that there are enough,   ",
    "start": "567000",
    "end": "575000"
  },
  {
    "text": "there are not enough mitogenic growth factors to justify   proliferation then they'll jump out of the active cell cycle and go back  ",
    "start": "575000",
    "end": "583000"
  },
  {
    "text": "to G zero.  What that means,  in effect, is as follows.  Once the   cells have passed through the R point and they're over here and they  ",
    "start": "583000",
    "end": "590000"
  },
  {
    "text": "are committed to complete the rest of the cell cycle then you can take   growth factors out of their medium and they don't care because they  ",
    "start": "590000",
    "end": "598000"
  },
  {
    "text": "only want to receive these stimulatory signals.    They only care about in this window of time.  Hereafter,   ",
    "start": "598000",
    "end": "606000"
  },
  {
    "text": "they're committed essentially irreversibly to go through the rest   of the cell cycle.  There are, as it turns out,   ",
    "start": "606000",
    "end": "615000"
  },
  {
    "text": "also growth inhibitory factors.  So, here we've been talking about   mitogens, the growth inhibitory factors.  So, an important growth  ",
    "start": "615000",
    "end": "625000"
  },
  {
    "start": "620000",
    "end": "827000"
  },
  {
    "text": "inhibitory factor is, for example, TGF beta.    And TGF beta works exactly opposite to PDGF because it is a single which  ",
    "start": "625000",
    "end": "634000"
  },
  {
    "text": "is present in extracellular space and tells the cell it should stop   proliferating.  And, therefore,   ",
    "start": "634000",
    "end": "642000"
  },
  {
    "text": "TGF beta, if it's present in large amounts in this part of the cell   cycle, if the cell experiences it in large amounts,   ",
    "start": "642000",
    "end": "651000"
  },
  {
    "text": "that will influence the cell not to move through the restriction point.    Conversely, if it's absent then obviously PDGF can have the,   ",
    "start": "651000",
    "end": "659000"
  },
  {
    "text": "the undiluted tensions of the cell.  And, therefore,    what I'm trying to convey by this is to tell you that cell balances both  ",
    "start": "659000",
    "end": "668000"
  },
  {
    "text": "its growth stimulatory and growth inhibitory signals that it's   receiving from extracellular space,  these decisions are weighed, and  ",
    "start": "668000",
    "end": "676000"
  },
  {
    "text": "finally down here the cell with make the, the binary decision to go ahead   or not to go ahead,  depending on historically how many  ",
    "start": "676000",
    "end": "684000"
  },
  {
    "text": "of these factors its recruited in this specific window of time.    Recall, as we said last time,  that once a growth factor like PDGF  ",
    "start": "684000",
    "end": "693000"
  },
  {
    "text": "goes to the plasma membrane it encounters a receptor on the surface   which let's say we call the PDGF receptor.  And I'll just draw it  ",
    "start": "693000",
    "end": "702000"
  },
  {
    "text": "like this for the moment.  It's a transmembrane protein.    The extracellular domain is on the outside.  And I'm drawing two copies  ",
    "start": "702000",
    "end": "711000"
  },
  {
    "text": "of the PDGF receptor here for reasons that will become   apparent in a moment.  And what happens is that PDGF which,   ",
    "start": "711000",
    "end": "720000"
  },
  {
    "text": "for example, can be itself a dimer-,  it can be a dimeric growth factor.    So, it has two distinct subunits in it.  They're both essentially  ",
    "start": "720000",
    "end": "729000"
  },
  {
    "text": "equivalent to one another but it is dimeric.  And this dimeric structure,    PDGF, allows it to bind to two growth factor receptors  ",
    "start": "729000",
    "end": "738000"
  },
  {
    "text": "simultaneously.  Well, why is that interesting?    It's interesting for the following reason.   ",
    "start": "738000",
    "end": "747000"
  },
  {
    "text": "These transmembrane PDGF receptors,  like the ones I've indicated right   here, they're anchored in the plasma membrane because there's a portion  ",
    "start": "747000",
    "end": "755000"
  },
  {
    "text": "of their sequence right in here in the transmembrane domain,    I'm indicating it here in the orange,  which contains highly hydrophobic  ",
    "start": "755000",
    "end": "763000"
  },
  {
    "text": "amino acids.  And those hydrophobic amino acids obviously love to be in   this hydrophobic environment of the lipid bilayer and their,   ",
    "start": "763000",
    "end": "771000"
  },
  {
    "text": "by they don't, they have no effect at all on whether the PDGF receptors   can move, can traverse in the plane of the plasma membrane.   ",
    "start": "771000",
    "end": "780000"
  },
  {
    "text": "So, the PDGF receptors can move across the face of the plasma   membrane.  These ones can move to the right or the left,   ",
    "start": "780000",
    "end": "787000"
  },
  {
    "text": "but they're not going to come in or out because they're anchored in this   lipid bilayer by this stretch of hydrophobic amino acids.   ",
    "start": "787000",
    "end": "794000"
  },
  {
    "text": "Now, what happens interestingly when PDGF, the dimeric receptor   binds to two of these PDGF receptor molecules, which,   ",
    "start": "794000",
    "end": "801000"
  },
  {
    "text": "as I told you, have lateral freedom to translate laterally on the plane   of a plasma membrane,  what happens is it will bind two of  ",
    "start": "801000",
    "end": "808000"
  },
  {
    "text": "these receptors.  And, in so doing,    it will pull the two receptor molecules next to one another.   ",
    "start": "808000",
    "end": "816000"
  },
  {
    "text": "Previously, they were just floating around in the plane of the plasma   membrane having bound their ligand,  recall that PDGF is considered a  ",
    "start": "816000",
    "end": "826000"
  },
  {
    "text": "ligand for the PDGF receptor,  having, it will cause these two   receptor molecules to now become,  become pulled very close to one  ",
    "start": "826000",
    "end": "835000"
  },
  {
    "text": "another.  So, I'll redraw it now like this.    Now these two receptor molecules look like this,   ",
    "start": "835000",
    "end": "843000"
  },
  {
    "text": "they're right, they're cheek by jowl,  they're right next to one another,    and this has some interesting consequences.  Of great interest  ",
    "start": "843000",
    "end": "851000"
  },
  {
    "text": "here is the affect this has on the ability of the PDGF receptor to emit   signals into the cytoplasm.  Because recall that the end game  ",
    "start": "851000",
    "end": "858000"
  },
  {
    "text": "here is always how does the,  how does the intracellular part of   the cell know that this,  there's been an encounter with the  ",
    "start": "858000",
    "end": "866000"
  },
  {
    "text": "growth factor in the extracellular space?    And this signal-emitting power to PDGF receptor comes from the fact  ",
    "start": "866000",
    "end": "875000"
  },
  {
    "text": "that once these two domains are brought together,    each of these two domains is able to modify the other and change the  ",
    "start": "875000",
    "end": "885000"
  },
  {
    "text": "other, i.e., subunit A modifies subunit B, subunit B modifies   subunit A.  And how is this modification achieved?   ",
    "start": "885000",
    "end": "895000"
  },
  {
    "text": "For the follow, it is achieved in the following way.    That the, this domain,  which I've been calling,   ",
    "start": "895000",
    "end": "904000"
  },
  {
    "text": "I've just been writing like this,  as a rectangle, is actually a   catalytic agent.  It's actually a tyrosine kinase.   ",
    "start": "904000",
    "end": "913000"
  },
  {
    "start": "910000",
    "end": "965000"
  },
  {
    "text": "So, it's an enzyme.  And a tyrosine kinase is an enzyme that takes the   gamma phosphate from ATP,  the high energy phosphate from APT,   ",
    "start": "913000",
    "end": "922000"
  },
  {
    "text": "ATP and transfers it to tyrosine amino acids that are present   on substrates.  So, if here is an amino acid  ",
    "start": "922000",
    "end": "931000"
  },
  {
    "text": "sequence in the single letter,  letter code, and if we admit that Y   is the, is the code for tyrosine then if here's a protein that it  ",
    "start": "931000",
    "end": "940000"
  },
  {
    "text": "functions as a substrate for a tyrosine kinase,    a tyrosine kinase will add a phosphate group to the side chain of  ",
    "start": "940000",
    "end": "948000"
  },
  {
    "text": "the tyrosine, which I'm not drawing here, but tyrosine has a hydroxyl   group in its side chain and,  therefore, it will phosphorilate  ",
    "start": "948000",
    "end": "957000"
  },
  {
    "text": "this tyrosine.  That is to say will tetraphosphate   group do it?  It will phosphorilate this tyrosine.   ",
    "start": "957000",
    "end": "966000"
  },
  {
    "start": "965000",
    "end": "1103000"
  },
  {
    "text": "So, these two rectangles are,  in fact, tyrosine kinases.  And what   happens, after the two subunits of the receptor have been brought  ",
    "start": "966000",
    "end": "976000"
  },
  {
    "text": "together, is thereafter,  what one finds is that each of these   receptor subunits becomes multiply phosphorilated.   ",
    "start": "976000",
    "end": "985000"
  },
  {
    "text": "And each of these lollipops that I'm indicating here are sites where   there, a tyrosine residue has become phosphorilated.   ",
    "start": "985000",
    "end": "995000"
  },
  {
    "text": "In fact, there's a tail of the PDGF receptor that extends even further   to the cytoplasm which also acquires a number of different phosphates on  ",
    "start": "995000",
    "end": "1002000"
  },
  {
    "text": "it.  And, again,  I'd remind us that this   phosphorylation is really what's often called transphosphorylation  ",
    "start": "1002000",
    "end": "1010000"
  },
  {
    "text": "because each receptor molecule phosphorilates the tyrosine residues   on the other.  Obviously,  when these two receptor molecules  ",
    "start": "1010000",
    "end": "1017000"
  },
  {
    "text": "are far apart in the plain of the plasma membrane,    this transphosphorylation cannot occur.   ",
    "start": "1017000",
    "end": "1025000"
  },
  {
    "text": "But once the two tyrosine kinase residues, once the two tyrosine   kinases have been brought together,  pulled together by the dimerization  ",
    "start": "1025000",
    "end": "1033000"
  },
  {
    "text": "of the receptor,  now this cross-phosphorylation,    on each phosphorylating the other can occur, and soon the receptors  ",
    "start": "1033000",
    "end": "1042000"
  },
  {
    "text": "are highly phosphorilated.  All of these phosphate groups,    to repeat myself, being attached to tyrosine residues in their  ",
    "start": "1042000",
    "end": "1050000"
  },
  {
    "text": "cytoplasmic domains.  And this, in turn,    creates interesting docking sites for a variety of other cytoplasmic  ",
    "start": "1050000",
    "end": "1059000"
  },
  {
    "text": "signaling proteins.  And we'll talk about some today and   next time, but what I want to leave you with is the following impression.   ",
    "start": "1059000",
    "end": "1069000"
  },
  {
    "text": "That after this phosphorylation actually occurs there are a number   of molecules in the cytoplasm,  signaling molecules that have  ",
    "start": "1069000",
    "end": "1078000"
  },
  {
    "text": "affinity for binding these phosphotyrosines.    When I say phosphotyrosine,  obviously, I'm referring to the  ",
    "start": "1078000",
    "end": "1087000"
  },
  {
    "text": "phosphorilated form of tyrosine that's been created by a tyrosine   kinase enzyme.  So, here's one molecule that can  ",
    "start": "1087000",
    "end": "1095000"
  },
  {
    "text": "bind.  Here's molecule A combined to one of these phosphates,    another one combined to this phosphate specifically,   ",
    "start": "1095000",
    "end": "1103000"
  },
  {
    "start": "1103000",
    "end": "1241000"
  },
  {
    "text": "and each of these molecules,  once they're attracted to this   phosphorilated receptor,  can then emit downstream signals,   ",
    "start": "1103000",
    "end": "1111000"
  },
  {
    "text": "send a variety of signals into the cell that ultimately end up in   persuading the cell to proliferate.   ",
    "start": "1111000",
    "end": "1120000"
  },
  {
    "text": "And so these effects here of growth factors in the G1 phase of the cell   cycle are mediated by this transmembrane signaling,   ",
    "start": "1120000",
    "end": "1130000"
  },
  {
    "text": "by the activation of these,  of this PDGF receptor, for example,    and by the resulting a release of downstream signals into the cell  ",
    "start": "1130000",
    "end": "1140000"
  },
  {
    "text": "which pursued the cell to proliferate or not to proliferate.    To be sure the,  when platelets clot,   ",
    "start": "1140000",
    "end": "1148000"
  },
  {
    "text": "when platelets aggregate and they release PDGF, they also release   other kinds of growth factors.  For instance, there's another  ",
    "start": "1148000",
    "end": "1155000"
  },
  {
    "text": "growth factor that's called IGF1,  insulin-like growth factor, and that   has its own receptor on the surface of cells.  And there are,   ",
    "start": "1155000",
    "end": "1162000"
  },
  {
    "text": "on a cell, hundreds to thousands of these PDGF receptors,    there are IGF receptors,  there are EGF receptors.   ",
    "start": "1162000",
    "end": "1170000"
  },
  {
    "text": "And a cell often will require several distinct kinds of growth   factor activations in order to proliferate.  So,   ",
    "start": "1170000",
    "end": "1178000"
  },
  {
    "text": "this is only a minor part of the entire exposure that a cell   experiences in the G1 phase of the cell cycle.  To elaborate on a point  ",
    "start": "1178000",
    "end": "1187000"
  },
  {
    "text": "that I made last time,  an important biological distinction   between normal cells and cancer cells is the fact that cancer cells  ",
    "start": "1187000",
    "end": "1195000"
  },
  {
    "text": "require relatively little growth factors or in the medium in order to   proliferate.  Normal cells have a very strong  ",
    "start": "1195000",
    "end": "1204000"
  },
  {
    "text": "requirement for growth factors in their medium.  And,    therefore, what we can already imagine is the following kind of  ",
    "start": "1204000",
    "end": "1213000"
  },
  {
    "text": "scenario.  That cancer cells have someone deregulated this signaling   pathway.  Somehow they have become independent of the stimulation that  ",
    "start": "1213000",
    "end": "1221000"
  },
  {
    "text": "is normally required,  usually required for cells to   proliferate.  And,  in fact, we know of several  ",
    "start": "1221000",
    "end": "1230000"
  },
  {
    "text": "different ways by which cancer cells can acquire this independence.    One of the most important ways,  it's, it a really interesting one,   ",
    "start": "1230000",
    "end": "1239000"
  },
  {
    "text": "is here's a cancer cell, which we'll talk about very shortly.    And what you find in certain kinds of cancer cells is that the cancer  ",
    "start": "1239000",
    "end": "1247000"
  },
  {
    "start": "1241000",
    "end": "1380000"
  },
  {
    "text": "cells themselves release growth factors into the medium.    So, there are certain kinds of cancer cells that will release,   ",
    "start": "1247000",
    "end": "1256000"
  },
  {
    "text": "let's say, a growth factor that's like EGF into the medium around it,    around themselves.  Well, you'll say that's kind of  ",
    "start": "1256000",
    "end": "1265000"
  },
  {
    "text": "amusing.  But so what.  The important part here is that   these same cancer cells have receptors for TG,   ",
    "start": "1265000",
    "end": "1273000"
  },
  {
    "text": "for EGF on their surface.  So, they're producing a growth   factor and they can also respond to the same growth factor.   ",
    "start": "1273000",
    "end": "1281000"
  },
  {
    "text": "And, therefore, this EGF,  once it's released, can swim over   here, activate the receptor and pursued the cell to start  ",
    "start": "1281000",
    "end": "1289000"
  },
  {
    "text": "proliferating.  This is, if you will,    a positive feedback loop.  But note here importantly that this,   ",
    "start": "1289000",
    "end": "1297000"
  },
  {
    "text": "the growth of this cell is not being controlled by growth factors coming   from cells elsewhere in the tissue or the body.  Here we're not talking  ",
    "start": "1297000",
    "end": "1305000"
  },
  {
    "text": "about different cells talking to one another.  Here we're talking about a   monologue where this cell is talking to itself.  This is sometimes called  ",
    "start": "1305000",
    "end": "1313000"
  },
  {
    "text": "autocrine signaling and refers to the fact that certain kinds of   cancer cells are able to make growth factors to which they can respond.   ",
    "start": "1313000",
    "end": "1322000"
  },
  {
    "text": "In fact, in normal tissues it's rare for a single cell type in a normal   tissue to be able to make a growth factor and to be able to respond to  ",
    "start": "1322000",
    "end": "1329000"
  },
  {
    "text": "the same growth factor.  Why can it normally not respond to   that growth factor?  Because it won't make the receptor  ",
    "start": "1329000",
    "end": "1337000"
  },
  {
    "text": "for the growth factor.  For example, epithelial cells like   the cells in your skin or the cells lining the gut,   ",
    "start": "1337000",
    "end": "1345000"
  },
  {
    "text": "they can release PDGF,  but they don't have a PDGF receptor   on their surface.  And, therefore,   ",
    "start": "1345000",
    "end": "1352000"
  },
  {
    "text": "even though they release copious amounts of PDGF,    that will not result in this auto stimulatory proliferation and,   ",
    "start": "1352000",
    "end": "1360000"
  },
  {
    "text": "therefore, you don't have this decontrolled self-proliferation that   you see often in cancer cells,  this autocrine loop.  In many kinds  ",
    "start": "1360000",
    "end": "1368000"
  },
  {
    "text": "of cancer cells you have another alteration of this growth factor   signaling pathway.  And here what we see is the  ",
    "start": "1368000",
    "end": "1376000"
  },
  {
    "text": "following.  Instead of there being a small number of growth factor   receptors on the cell surface,  now there are ten or twenty or fifty  ",
    "start": "1376000",
    "end": "1384000"
  },
  {
    "start": "1380000",
    "end": "1656000"
  },
  {
    "text": "times more than are normally present on the cell surface.    In other words,  this growth, the growth factor  ",
    "start": "1384000",
    "end": "1391000"
  },
  {
    "text": "receptors are what is called overexpressed.     And, therefore,   ",
    "start": "1391000",
    "end": "1403000"
  },
  {
    "text": "a delicate balance is disrupted because normally,    let's say, a cell with have on its surface 500 EGF receptors,   ",
    "start": "1403000",
    "end": "1411000"
  },
  {
    "text": "but in many kinds of cancers probably 30% or 40% of all   carcinomas, carcinomas are the tumors from epithelial tissues,   ",
    "start": "1411000",
    "end": "1419000"
  },
  {
    "text": "you'll find overexpressed EGF receptor.  Well,    why is that interesting?  It's interesting for the following  ",
    "start": "1419000",
    "end": "1426000"
  },
  {
    "text": "reason.  I told you before that the activation of a receptor depends on   its ligand to persuading two receptor subunits to come together  ",
    "start": "1426000",
    "end": "1434000"
  },
  {
    "text": "and start firing, as we just discussed.    But if now all of a sudden the cell contains large amounts of this  ",
    "start": "1434000",
    "end": "1441000"
  },
  {
    "text": "growth being expressed,  of the growth factor receptor being   expressed on the surface,  ten or a hundred times more than  ",
    "start": "1441000",
    "end": "1447000"
  },
  {
    "text": "normal, then these growth factor receptors are going to be rather   densely packed on the cell surface.  And now they may just come together  ",
    "start": "1447000",
    "end": "1454000"
  },
  {
    "text": "because they happen to bump into each other very frequently.    They don't need the growth factor to pull them together just because  ",
    "start": "1454000",
    "end": "1461000"
  },
  {
    "text": "there are so many of them.  So, there's random interactions,    random bumping together And these two growth factor  ",
    "start": "1461000",
    "end": "1467000"
  },
  {
    "text": "receptors may just bump together and thereby send signals into the cell   persuading the cell that there's been some kind of growth factor in  ",
    "start": "1467000",
    "end": "1475000"
  },
  {
    "text": "the extracellular domain that's been encountered when,    in fact, all that's happened is that there are so many of these growth  ",
    "start": "1475000",
    "end": "1482000"
  },
  {
    "text": "factor receptors around that they're constantly bumping into each other,    and while they've collided with one another they can activate signaling  ",
    "start": "1482000",
    "end": "1490000"
  },
  {
    "text": "and release growth stimulatory signals into the cell.    There's another kind of,  of alteration of growth factor  ",
    "start": "1490000",
    "end": "1498000"
  },
  {
    "text": "receptors that's also seen in many kinds of human tumors.    For example, in, in glioblastomas,  which is a brain tumor.  And a  ",
    "start": "1498000",
    "end": "1508000"
  },
  {
    "text": "glioblastoma has the following kind of, of receptor on the surface.    It has truncated forms of the EGF receptor on the surface where a lot  ",
    "start": "1508000",
    "end": "1518000"
  },
  {
    "text": "of the ectodomain is simply not present.  So, here's the normal EGF   receptor, here is a truncated EGF receptor where a lot of the  ",
    "start": "1518000",
    "end": "1527000"
  },
  {
    "text": "extracellular domain,  which I'm calling the ectodomain,    has simply been lopped off.  How has it be lopped off?   ",
    "start": "1527000",
    "end": "1537000"
  },
  {
    "text": "Well, there's been a mutation it the gene which has,    in effect, deleted segments in coding the N-terminus of the  ",
    "start": "1537000",
    "end": "1545000"
  },
  {
    "text": "receptor protein,  which normally sticks its head out   of the cell.  And now you have these truncated receptors.   ",
    "start": "1545000",
    "end": "1554000"
  },
  {
    "text": "And such truncated EGF receptors are able to fire constitutively.    Constitutively implies that these receptors are able to fire in a  ",
    "start": "1554000",
    "end": "1562000"
  },
  {
    "text": "fashion that is no longer regulated by physiologic signals.    It's a high steady rate.  So now these receptor molecules,   ",
    "start": "1562000",
    "end": "1570000"
  },
  {
    "text": "these truncated receptor molecules flood the cell with growth   stimulatory signal and,  for reasons that aren't really clear  ",
    "start": "1570000",
    "end": "1578000"
  },
  {
    "text": "to this day, these two,  these receptor, truncated receptor   molecules can dimerize,  they can come together even if  ",
    "start": "1578000",
    "end": "1586000"
  },
  {
    "text": "there's no extracellular ligand present, even if there's no growth   factor in the extracellular space.  And we now realize,   ",
    "start": "1586000",
    "end": "1594000"
  },
  {
    "text": "for example, that there are a variety of structurally altered   receptors that fire constitutively into a cell in many kinds of human  ",
    "start": "1594000",
    "end": "1602000"
  },
  {
    "text": "tumors.  And in each case the cancer cell is deluded into thinking that   some growth factor has been encountered out here when,   ",
    "start": "1602000",
    "end": "1610000"
  },
  {
    "text": "in fact, there's not at all.  Once again, what we see is a   situation in which the cell,  the cancer cell is being deluded  ",
    "start": "1610000",
    "end": "1618000"
  },
  {
    "text": "into thinking there's growth factors present, extracellular space.    None has been present at all.  There have been a variety of drugs  ",
    "start": "1618000",
    "end": "1627000"
  },
  {
    "text": "developed against,  for example, lung cancer.    And there are a variety of different kinds of lung cancers.   ",
    "start": "1627000",
    "end": "1637000"
  },
  {
    "text": "One is called non-small cell lung carcinoma.  We don't have to deal   with the subsets of lung cancers.  And it turned out, it turned out  ",
    "start": "1637000",
    "end": "1646000"
  },
  {
    "text": "that one of these drugs,  it's called Iressa, had very mixed   effects on patients.    ",
    "start": "1646000",
    "end": "1658000"
  },
  {
    "text": "In about 90% of these,  of the class of lung cancers,    patients that were treated, the drug Iressa, used over the last several  ",
    "start": "1658000",
    "end": "1667000"
  },
  {
    "text": "years, had almost no effect on the tumor treatment and the patients   continued to, to proceed to their death.  It had,   ",
    "start": "1667000",
    "end": "1676000"
  },
  {
    "text": "it really had no effect.  But in 10%, in fact, there was some   dramatic responses and tumors shrunk down.   ",
    "start": "1676000",
    "end": "1685000"
  },
  {
    "text": "Now, normally a 10% response rate would be enough to cause a drug   company to abandon all further development of the drug because it's  ",
    "start": "1685000",
    "end": "1693000"
  },
  {
    "text": "just too low a response and who wants to take a drug where the   chances of having a good response are as low as 10%?   ",
    "start": "1693000",
    "end": "1701000"
  },
  {
    "text": "It's just not a good situation.  But then some geneticists here in   Boston, one group at the MGH and another over at the Dana Farber,   ",
    "start": "1701000",
    "end": "1709000"
  },
  {
    "text": "began to look at the lung cancer cells that responded,    i.e., from tumors of patients that responded and shrank in response to  ",
    "start": "1709000",
    "end": "1717000"
  },
  {
    "text": "the drug and the lung,  and the lung cancer cells of   patients who didn't.  It turns out that Iressa is an  ",
    "start": "1717000",
    "end": "1724000"
  },
  {
    "text": "inhibitor of the tyrosine kinase of the EGF receptor.    That's how it was designed.  In other words, this drug, it's a  ",
    "start": "1724000",
    "end": "1732000"
  },
  {
    "text": "low molecular weight drug and it goes into the tyrosine kinase domain,    that rectangular thing I showed you before very schematically,   ",
    "start": "1732000",
    "end": "1740000"
  },
  {
    "text": "and it shuts down the firing of the receptor.    That was the motivation behind creating this drug.   ",
    "start": "1740000",
    "end": "1748000"
  },
  {
    "text": "So, Iressa shuts down the EGF receptor and 10% of lung cancer   patients, their tumor shrank,  the other 90% didn't, weren't  ",
    "start": "1748000",
    "end": "1758000"
  },
  {
    "text": "effected at all.  And what these two groups of   geneticists found over the last three or four months is that the  ",
    "start": "1758000",
    "end": "1767000"
  },
  {
    "text": "patients whose tumors responded had tumor cells where the EGF receptor   was mutated and therefore firing in a constitutively active fashion.   ",
    "start": "1767000",
    "end": "1777000"
  },
  {
    "text": "That is to say there were actually structural alterations in the   receptor.  This is a massive structural alteration of the  ",
    "start": "1777000",
    "end": "1784000"
  },
  {
    "text": "receptor here,  this truncation.    But, in fact, in certain patients the 10% of patients that responded,   ",
    "start": "1784000",
    "end": "1792000"
  },
  {
    "text": "there were much more subtle changes in the cytoplasmic domain of the   protein which allowed these receptors to constitutively dimerize,   ",
    "start": "1792000",
    "end": "1800000"
  },
  {
    "text": "once again, in a ligand independent fashion.    So, these subtle mutations mimic,  in effect, the consequences of  ",
    "start": "1800000",
    "end": "1808000"
  },
  {
    "text": "deleting or truncating the extracellular domain in that in both   cases one gets a ligand independent receptor.  In those cases where  ",
    "start": "1808000",
    "end": "1816000"
  },
  {
    "text": "these, where the patients had a mutant EGF receptor,    structurally altered EGF receptor that was firing constitutively,   ",
    "start": "1816000",
    "end": "1824000"
  },
  {
    "text": "there were dramatic responses to the Iressa drug.    In the 90% of patients where there was no effective response to the  ",
    "start": "1824000",
    "end": "1831000"
  },
  {
    "text": "drug, the EGF receptor was wild-type,  it was present in a wild-type   configuration.  It might have been slightly  ",
    "start": "1831000",
    "end": "1839000"
  },
  {
    "text": "overexpressed but it wasn't,  but it continued to, to function   essentially as a normal EGF receptor.  And this represents a major advance  ",
    "start": "1839000",
    "end": "1846000"
  },
  {
    "text": "in cancer therapy because it suggests that one has to begin to   understand what subsets of patients one should treat with a drug which  ",
    "start": "1846000",
    "end": "1854000"
  },
  {
    "text": "can, on its own,  have quite toxic effects on the   patient.  And, from now on,   ",
    "start": "1854000",
    "end": "1861000"
  },
  {
    "text": "to state the obvious,  when one gets lung cancer patients   one will check quickly using various reactions, like the PCR reaction,   ",
    "start": "1861000",
    "end": "1869000"
  },
  {
    "text": "to see whether or not their cancer cells have a mutated EGF receptor.    And, if they do, they will be candidates for Iressa treatment with  ",
    "start": "1869000",
    "end": "1876000"
  },
  {
    "text": "the expectation that 60%,  80% or even 100% of them will have   tumors that respond.  And if they don't have a mutated  ",
    "start": "1876000",
    "end": "1884000"
  },
  {
    "text": "EGF receptor then they will not be subjected to a treatment   by this drug.  This is the beginning of a new era  ",
    "start": "1884000",
    "end": "1891000"
  },
  {
    "text": "of cancer drug treatment.  It's called rational drug design,    or rational treatment, where you don't just lump all the patients  ",
    "start": "1891000",
    "end": "1899000"
  },
  {
    "text": "with a certain disease together and say let's give them all this drug   and throw things up in the air and see what happens.   ",
    "start": "1899000",
    "end": "1906000"
  },
  {
    "text": "Here one begins to do a genetic diagnosis of the genomes of the   patient's cancer cells in order to determine whether or not they have  ",
    "start": "1906000",
    "end": "1914000"
  },
  {
    "text": "certain mutated genes.  In this case we're referring to one   of these growth factor receptors.  By the way, we're talking about lung  ",
    "start": "1914000",
    "end": "1922000"
  },
  {
    "start": "1919000",
    "end": "2323000"
  },
  {
    "text": "cancer today, right?  If you are smoking now,    I always ask the class how many people are smoking,   ",
    "start": "1922000",
    "end": "1930000"
  },
  {
    "text": "and nobody has the, has the moral fortitude to raise their hands.    But if you are smoking now and you started at this age and you continue.   ",
    "start": "1930000",
    "end": "1938000"
  },
  {
    "text": "And, by the way,  if you start at your age and you   continue smoke,  stopping smoking is actually a bit  ",
    "start": "1938000",
    "end": "1946000"
  },
  {
    "text": "more difficult,  quite a bit more difficult than   stopping heroine.  That's pretty interesting,   ",
    "start": "1946000",
    "end": "1954000"
  },
  {
    "text": "right?  So, if you continue to smoke now you will be healthy for a pretty   long period of time,  probably another 20 or 30 years.   ",
    "start": "1954000",
    "end": "1962000"
  },
  {
    "text": "And for you that sounds like forever, but when you get to be   about 40 or 50 things are going to start falling apart.   ",
    "start": "1962000",
    "end": "1970000"
  },
  {
    "text": "Soon you won't be able to be very athletic, soon your lungs are going   to be able, are going to degrade,  and by the time you reach your  ",
    "start": "1970000",
    "end": "1978000"
  },
  {
    "text": "fifties, sixties or seventies what's going to happen is you will,    on average, have a six to eight year shortened life expectancy.   ",
    "start": "1978000",
    "end": "1986000"
  },
  {
    "text": "Now you say six to eight years is not that much,    but it really is.  You know, when you get to be 70 and  ",
    "start": "1986000",
    "end": "1993000"
  },
  {
    "text": "you think you're going to die next year or you're going to die in six   or eight years it makes a big difference.  Six to eight years is  ",
    "start": "1993000",
    "end": "2000000"
  },
  {
    "text": "an enormous difference in life expectancy.  20% of all people who   died last year in this country,  20% of all deaths came from  ",
    "start": "2000000",
    "end": "2008000"
  },
  {
    "text": "cigarette smoking.  Imagine that.  And when you die from cigarette   smokes, smoking sometimes you get lung cancer.  There probably were,   ",
    "start": "2008000",
    "end": "2016000"
  },
  {
    "text": "I think, 600,000 people who died from smoking last year.    Six hundred thousand.  There were 55,000 American soldiers who died in  ",
    "start": "2016000",
    "end": "2024000"
  },
  {
    "text": "Vietnam in the whole war,  there were 220,000 American soldiers   who died in all of World War II,  and last year in this, and there  ",
    "start": "2024000",
    "end": "2032000"
  },
  {
    "text": "were 3,000, or 2,  00 people who died in the World   Trade Center.  All right?  Got all those numbers?   ",
    "start": "2032000",
    "end": "2040000"
  },
  {
    "text": "So, last year 600,  00 people died premature deaths   because they were smoking.  How many people died last year from  ",
    "start": "2040000",
    "end": "2050000"
  },
  {
    "text": "smoking marijuana?  Maybe two or three,    I don't know.  [APPLAUSE]  Am I urging you to do any kind of smoking?   ",
    "start": "2050000",
    "end": "2060000"
  },
  {
    "text": "I'm not saying marijuana smoking is good for you, but I just want you to   get these things in mind,  the perspective.   ",
    "start": "2060000",
    "end": "2070000"
  },
  {
    "text": "If you smoke, you know,  in many countries, including this   one, there isn't much tension by,  given by the government to,   ",
    "start": "2070000",
    "end": "2077000"
  },
  {
    "text": "dissuading people from smoking,  and here's the reason why.  If you   smoke, and you going to get,  get sick eventually, eventually the  ",
    "start": "2077000",
    "end": "2084000"
  },
  {
    "text": "country is always going to have to pay for your medical costs,    right?  Sooner or later we all have to pay for the costs of people who  ",
    "start": "2084000",
    "end": "2091000"
  },
  {
    "text": "get sick.  It's all shared in one way or another.    But it's not such a big problem for a government like the  ",
    "start": "2091000",
    "end": "2098000"
  },
  {
    "text": "American government.  Because if you smoke you're going to   die early enough that you won't draw on social security.   ",
    "start": "2098000",
    "end": "2106000"
  },
  {
    "text": "And, therefore, the government actually saves money by your smoking,    because by the time they add up how much they get on the tobacco tax and  ",
    "start": "2106000",
    "end": "2114000"
  },
  {
    "text": "how much they earn by your not living long enough to draw a pension,    it's much better,  it's much more money than how much  ",
    "start": "2114000",
    "end": "2122000"
  },
  {
    "text": "it's going to cost to take care of you while you're dying from   emphysema or bladder cancer or lung cancer or heart disease.   ",
    "start": "2122000",
    "end": "2130000"
  },
  {
    "text": "Many more people die from heart attacks due to smoking than die from   lung cancer, in fact.  So, think about this.   ",
    "start": "2130000",
    "end": "2137000"
  },
  {
    "text": "Think about this.  If you smoke it's probably a good time to stop   because if you continue at your age,  especially if you're women, which is  ",
    "start": "2137000",
    "end": "2145000"
  },
  {
    "text": "women, for some reason women have a harder time stopping than men,    they can't say why.  It's probably some physiological thing.   ",
    "start": "2145000",
    "end": "2152000"
  },
  {
    "text": "If you, if you continue now at your age, it will be almost impossible to   stop.  If you live with smokers ask them to leave.  [LAUGHTER]  ",
    "start": "2152000",
    "end": "2160000"
  },
  {
    "text": "If you live at home with your parents and they smoke tell them   it's time for them to leave.  Throw them out of the house.   ",
    "start": "2160000",
    "end": "2168000"
  },
  {
    "text": "Smoke, second-hand smoking killed probably between 60,    00 and 80,000 people last year in this country.  Second-hand smoke.   ",
    "start": "2168000",
    "end": "2176000"
  },
  {
    "text": "And, by the way, if you want to see an interesting phenomenon,    go to a veterinary hospital because there they with great frequently,   ",
    "start": "2176000",
    "end": "2184000"
  },
  {
    "text": "frequency treat dogs who have lung cancer.  And why do they   have lung cancer?  Not in 99% of the cases,   ",
    "start": "2184000",
    "end": "2192000"
  },
  {
    "text": "in 100% of the cases these dogs live with owners who smoke.    An average tobacco smoker goes through six or eight dogs in his or  ",
    "start": "2192000",
    "end": "2200000"
  },
  {
    "text": "her lifetime.  [LAUGHTER]  It's true.  It's absolutely true.    So if you, if you think the dogs,  if that's a fact for the, for the,   ",
    "start": "2200000",
    "end": "2209000"
  },
  {
    "text": "for the dog owners,  think about what's happening to the   inside of your lungs.  And so I'm going to take back what  ",
    "start": "2209000",
    "end": "2217000"
  },
  {
    "text": "I said before.  Before I told you that the most   important thing for you to do in this course is to learn how to think  ",
    "start": "2217000",
    "end": "2226000"
  },
  {
    "text": "clearly and to assess and to distil conceptually complex material,    there's actually one more thing that's even more important to get  ",
    "start": "2226000",
    "end": "2234000"
  },
  {
    "text": "out of this course,  if you do, and that is to stop   smoking.  If you do that,  if you do that it'll be vastly more  ",
    "start": "2234000",
    "end": "2242000"
  },
  {
    "text": "important for the rest of your life than anything you learn here.    So, write that down, vastly more important.  You may think it's  ",
    "start": "2242000",
    "end": "2250000"
  },
  {
    "text": "glamorous, you may think it's exciting, but keep in mind,    people who stop smoking have vastly greater effects on reducing the  ",
    "start": "2250000",
    "end": "2258000"
  },
  {
    "text": "morbidity and the mortality in this country than anything that cancer   researchers can do.  Keep that in mind.   ",
    "start": "2258000",
    "end": "2266000"
  },
  {
    "text": "And if you start smoking now and you think that somehow the cancer   researchers are going to be able to come up with some miracle cure by  ",
    "start": "2266000",
    "end": "2273000"
  },
  {
    "text": "this time you start coughing and start spitting up blood,    don't be so certain.  They may not be able to save you,   ",
    "start": "2273000",
    "end": "2280000"
  },
  {
    "text": "to pull your fat out of the fire.  So, I don't know whether I,    I gave this message in a very subtle way or I hit you over the head with  ",
    "start": "2280000",
    "end": "2288000"
  },
  {
    "text": "it.  [LAUGHTER]  But think,  think about that.  Now, now we're   going to focus on lung cancer,  we're going to focus on cancer  ",
    "start": "2288000",
    "end": "2296000"
  },
  {
    "text": "because it's one of the consequences of cigarette smoking,    but it's a disease we want to talk about both this time and next time,   ",
    "start": "2296000",
    "end": "2304000"
  },
  {
    "text": "and we want to relate it here to the cell cycle and,    and how the growth of cell proliferation occurs.   ",
    "start": "2304000",
    "end": "2312000"
  },
  {
    "text": "I told you last time that a human tumor is roughly-speaking about,    a human body roughly carries three times ten to the thirteenth cells.   ",
    "start": "2312000",
    "end": "2320000"
  },
  {
    "text": "So, that's quite a few cells.  That's how many cells there are in   the human body,  plus or minus.  A human tumor of one,   ",
    "start": "2320000",
    "end": "2328000"
  },
  {
    "start": "2323000",
    "end": "2371000"
  },
  {
    "text": "let's say one cubic centimeter is roughly ten to the ninth cells.    So, a tiny tumor this way already has a billion cells in it.   ",
    "start": "2328000",
    "end": "2336000"
  },
  {
    "text": "And what I want to say is that those billion cells,    or if the tumor grows larger to ten to a hundred billion cells,   ",
    "start": "2336000",
    "end": "2344000"
  },
  {
    "text": "it's still not that much compared with the overall size of the body.    But tumors of that size can kill you.  And one, an interesting and  ",
    "start": "2344000",
    "end": "2354000"
  },
  {
    "text": "important thing to realize about all the cancer cells in that tumor mass   is that they all descend from a single progenitor.   ",
    "start": "2354000",
    "end": "2364000"
  },
  {
    "text": "In other words, if we imagine a situation where here are a whole   bunch of normal cells and here's the boundary between normalcy up here  ",
    "start": "2364000",
    "end": "2374000"
  },
  {
    "start": "2371000",
    "end": "2490000"
  },
  {
    "text": "and malignancy,  malignancy obviously refers to  ",
    "start": "2374000",
    "end": "2380000"
  },
  {
    "text": "cancer, we could imagine where there are many cells which independently   cross the boundary from one to the other and become the progenitors of  ",
    "start": "2380000",
    "end": "2390000"
  },
  {
    "text": "a vast tumor mass.  But that's not what happens.    What happens, in fact, is that only one cell gets converted or becomes,   ",
    "start": "2390000",
    "end": "2400000"
  },
  {
    "text": "as one says here, it becomes transformed from a normal cell into   a cancer cell.  And this transformation causes this  ",
    "start": "2400000",
    "end": "2410000"
  },
  {
    "text": "one cell to become the progenitor,  the ancestor of all the cells in the   tumor mass.  So,  one important realization we have  ",
    "start": "2410000",
    "end": "2420000"
  },
  {
    "text": "about looking at different tumors is that cancers are monoclonal growths,    i.e., they form clonal populations.  They're monoclonal in the sense that  ",
    "start": "2420000",
    "end": "2430000"
  },
  {
    "text": "they all are genetically derived from a single common ancestor rather   than being polyclonal.  What else can we say about cancer  ",
    "start": "2430000",
    "end": "2440000"
  },
  {
    "text": "cells or the cells in a tumor?  If you take cells out of Petri dish,    out of an animal or a human and put them on a Petri dish,   ",
    "start": "2440000",
    "end": "2448000"
  },
  {
    "text": "excuse me, and you put them there,  then what you'll see is following   interesting behavior.  If you put normal cells in a Petri  ",
    "start": "2448000",
    "end": "2456000"
  },
  {
    "text": "dish they'll grow across the bottom of the Petri dish until they cover   the entire bottom of the Petri dish.   ",
    "start": "2456000",
    "end": "2464000"
  },
  {
    "text": "So, you can put a hundred cells in and they'll continue to proliferate.    Let's look at the Petri dish from top down, so you might have a small  ",
    "start": "2464000",
    "end": "2472000"
  },
  {
    "text": "number of cells here and here,  and normal cells will continue to   proliferate until they begin to touch one another,   ",
    "start": "2472000",
    "end": "2481000"
  },
  {
    "text": "and then they'll stop growing.  And this stopping of growing is,    is the phenomenon that's called contact inhibition.   ",
    "start": "2481000",
    "end": "2490000"
  },
  {
    "start": "2490000",
    "end": "2558000"
  },
  {
    "text": "So, a normal cell will indicate contact inhibition.    And to state, to state the obvious,  this phenomenon or this behavior of  ",
    "start": "2490000",
    "end": "2497000"
  },
  {
    "text": "contact inhibition creates what's called a cell monolayer because if   the cell stopped growing once they touch each other they're not going  ",
    "start": "2497000",
    "end": "2504000"
  },
  {
    "text": "to be two or three or four layers of cells in the Petri dish.    So, here we're looking at this Petri dish in cross-section and  ",
    "start": "2504000",
    "end": "2511000"
  },
  {
    "text": "there's a monolayer of normal cells here.    If you put a cancer cell in the Petri dish, or let's put here a  ",
    "start": "2511000",
    "end": "2518000"
  },
  {
    "text": "cancer cell, we'll seed it amidst normal cells, what will happen is   that the cancer cell lacks,  has lost contact inhibition,   ",
    "start": "2518000",
    "end": "2526000"
  },
  {
    "text": "and the cancer cell will continue to proliferate even after it's touched   its neighbors.  So, it has lost cancer,   ",
    "start": "2526000",
    "end": "2533000"
  },
  {
    "text": "it has lost contact inhibition and will start growing on top of,    the cancer cells will start growing on top of each other because they  ",
    "start": "2533000",
    "end": "2540000"
  },
  {
    "text": "don't mind growing in spite of their having intimate contact with   neighboring cells.  And, in fact, what you can do is  ",
    "start": "2540000",
    "end": "2548000"
  },
  {
    "text": "the following experiment.  You can put cells in a Petri dish   like this, a whole bunch of normal cells in a Petri dish,   ",
    "start": "2548000",
    "end": "2557000"
  },
  {
    "text": "and then you can put into them some kind of transforming influence,    which we'll talk about very shortly,  i.e., you can influence some of  ",
    "start": "2557000",
    "end": "2567000"
  },
  {
    "start": "2558000",
    "end": "2712000"
  },
  {
    "text": "these cells to become transformed.  And how we do so we'll tell, we'll   hold in abeyance just for a moment.  So, we'll have this cell. We'll do  ",
    "start": "2567000",
    "end": "2577000"
  },
  {
    "text": "this cell to become transformed and this cell to become transformed.    And what will happen is that those cells will begin to form a very  ",
    "start": "2577000",
    "end": "2585000"
  },
  {
    "text": "thick clump of cells,  these blue ones, the ones that are   transformed.  Whereas,  all the other cells will grow until  ",
    "start": "2585000",
    "end": "2593000"
  },
  {
    "text": "they form a monolayer at which point they'll stop proliferating.    So, the cancer cells keep piling up and the transformed cells,   ",
    "start": "2593000",
    "end": "2600000"
  },
  {
    "text": "transformed by one or another agent,  we won't talk about that yet,    continue to proliferate long after the normal cells have stopped  ",
    "start": "2600000",
    "end": "2608000"
  },
  {
    "text": "proliferating.  The normal cells having stopped   proliferating because they're contact inhibited.   ",
    "start": "2608000",
    "end": "2615000"
  },
  {
    "text": "And, therefore, they'll form this clump of cells which we'll call a   focus.  And if you hold the Petri dish up to the light and you look at  ",
    "start": "2615000",
    "end": "2622000"
  },
  {
    "text": "it and there are some transformed cells present,    you can see the foci,  they're very thick.  Whereas,   ",
    "start": "2622000",
    "end": "2629000"
  },
  {
    "text": "the thin monolayer of cells will just look pretty transparent.    But this focus will look highly opaque by virtue of the multiple  ",
    "start": "2629000",
    "end": "2636000"
  },
  {
    "text": "layers of cells that are involved in it.    Now, in fact, we can begin to ask the question of how and why cells  ",
    "start": "2636000",
    "end": "2645000"
  },
  {
    "text": "like this become transformed and exhibit this behavior.    In fact, until the 1980s there wasn't really a clear understanding  ",
    "start": "2645000",
    "end": "2656000"
  },
  {
    "text": "about how that happened.  I've already given you some clues   because I've already told you the fact that certain cancer cells carry  ",
    "start": "2656000",
    "end": "2667000"
  },
  {
    "text": "mutant genes.  What kind of mutant genes?    Well, I gave you, in anticipation of discussion,   ",
    "start": "2667000",
    "end": "2676000"
  },
  {
    "text": "the fact that certain cancer cells carry mutant genes that specify   mutant growth factor receptors.  And these mutant growth factor  ",
    "start": "2676000",
    "end": "2684000"
  },
  {
    "text": "receptors, as I indicated,  begin to push the cell the   proliferate.  And so that already anticipates a conclusion we're about  ",
    "start": "2684000",
    "end": "2693000"
  },
  {
    "text": "to make, which is that the reason why cancer cells behave abnormally   is that they carry mutant genes.  Now, let's talk about the nature of  ",
    "start": "2693000",
    "end": "2702000"
  },
  {
    "text": "these mutant genes because,  if you look at these mutant genes,    invariably they are the consequences of what we call somatic mutations.   ",
    "start": "2702000",
    "end": "2712000"
  },
  {
    "start": "2712000",
    "end": "2957000"
  },
  {
    "text": "By that I mean, I mean the following.  Let's say we all start   out with a really good set of genes.  And, thank the good Lord, we all do.   ",
    "start": "2712000",
    "end": "2722000"
  },
  {
    "text": "But as we go through life through accidents or through intent we can   damage these genes.  We can muck them up in different  ",
    "start": "2722000",
    "end": "2732000"
  },
  {
    "text": "ways.  And these genes,  this damage may occur to cells in   the skin, they may occur to cells in your belly, they may occur to cells  ",
    "start": "2732000",
    "end": "2741000"
  },
  {
    "text": "in the brain, and these are called somatic mutations in contrast to the   germline mutations that affect one's offspring.  Because,   ",
    "start": "2741000",
    "end": "2750000"
  },
  {
    "text": "as you must realize by now,  the only way you can have mutations   that affect your descendents is if those mutations strike in the gonads  ",
    "start": "2750000",
    "end": "2759000"
  },
  {
    "text": "and affect the genomes of either sperm or egg.    But the mutations occurring everywhere else in the body outside  ",
    "start": "2759000",
    "end": "2768000"
  },
  {
    "text": "of the gonads,  because they occur in,    I think I, this is somatic,  excuse me, because they occur in the  ",
    "start": "2768000",
    "end": "2776000"
  },
  {
    "text": "soma, the soma is defined as the entirety of the body outside of the   gonads, outside of the germi,  these somatic mutations might affect  ",
    "start": "2776000",
    "end": "2785000"
  },
  {
    "text": "the tissues around them but they will not be transmitted from one   organismic generation to the next.  And, accordingly,   ",
    "start": "2785000",
    "end": "2794000"
  },
  {
    "text": "we begin to imagine,  in fact, correctly we begin to   construct this model that one of the most important mechanisms of  ",
    "start": "2794000",
    "end": "2802000"
  },
  {
    "text": "creating a cancer cell is to damage its genome.  So,    I'll tell you a story now,  which I'm only going to finish on  ",
    "start": "2802000",
    "end": "2810000"
  },
  {
    "text": "Monday.  We have,  let's imagine, a 55-year-old,    this is a true story, 55-year-old man who's been smoking since he or  ",
    "start": "2810000",
    "end": "2818000"
  },
  {
    "text": "she, he was 15 years old.  So, he's been smoking for 40 years.    And during those periods of 40 years,  by the way, I'm not saying whether  ",
    "start": "2818000",
    "end": "2826000"
  },
  {
    "text": "I'm for or against smoking,  you understand that.  During that   period of 40 years this person has been introducing large amounts of  ",
    "start": "2826000",
    "end": "2835000"
  },
  {
    "text": "tobacco smoke compounds into his lungs.  Now, it turns out that these   compounds, this tobacco smoke compounds are carcinogens.   ",
    "start": "2835000",
    "end": "2843000"
  },
  {
    "text": "You know carcinogen means it causes cancer. But it happens also to be   the case that a lot of carcinogens,  cancer-causing compounds are also  ",
    "start": "2843000",
    "end": "2852000"
  },
  {
    "text": "mutagens.  That is to say they can mutate DNA.    So, here we have a scenario that we're going to set up for next time.   ",
    "start": "2852000",
    "end": "2861000"
  },
  {
    "text": "55-year-old man.  Smokes for 40 years.  Dumps a lot of carcinogens   into his lungs.  The carcinogens which are highly,   ",
    "start": "2861000",
    "end": "2870000"
  },
  {
    "text": "which induce mutations very potently are passed from his lungs into his   blood and there go from the blood into the kidneys.   ",
    "start": "2870000",
    "end": "2880000"
  },
  {
    "text": "And from the kidneys they are excreted into the urine and then   they sit around in the bladder for a while. And let's imagine now that  ",
    "start": "2880000",
    "end": "2889000"
  },
  {
    "text": "the urine of this man has all of these highly mutation-active   carcinogens in his urine,  which, in principle, can begin now  ",
    "start": "2889000",
    "end": "2898000"
  },
  {
    "text": "to strike out and attack the genomes of the cells lining the urinary   bladder.  In other words,  by, by smoking cigarettes you can  ",
    "start": "2898000",
    "end": "2907000"
  },
  {
    "text": "actually mutate the genomes,  somatic mutation, the genomes of   cells lining the bladder of the,  the urinary bladder, or, of course,   ",
    "start": "2907000",
    "end": "2917000"
  },
  {
    "text": "to state the obvious, you can also mutate the genomes of the cells   lining the alveoli in the lungs.  That's why you get lung cancer.   ",
    "start": "2917000",
    "end": "2926000"
  },
  {
    "text": "And a consequence of this can be,  with serious probability, that now   some of these cells become mutated and that, in turn,   ",
    "start": "2926000",
    "end": "2934000"
  },
  {
    "text": "will lead to a life-threatening tumor.  So, on this very cheerful   note and your having heard two major take-home lessons, have  ",
    "start": "2934000",
    "end": "2942000"
  },
  {
    "text": "a great weekend.  See you on Monday.  Enjoy   the parade tomorrow.  ",
    "start": "2942000",
    "end": "2948466"
  }
]